Ignite Creation Date:
2024-05-06 @ 10:25 AM
Last Modification Date:
2024-10-26 @ 12:30 PM
Study NCT ID:
NCT03257267
Status:
COMPLETED
Last Update Posted:
2023-07-11
First Post:
2017-07-26
Brief Title:
Study of Cemiplimab in Adults With Cervical Cancer
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Squamous Cell Carcinoma SCC |
| Recurrent or Metastatic Platinum-refractory Cervical Cancer |
Keywords: